This study aims to examine the influence of drug-free pectin hydrogel films on partial-thickness burn wounds using streptozotocin-induced diabetic rats as the animal model. Thirty male Sprague Dawley rats were included in the wound healing study, and scalding water was used to produce wounds in the dorsum region of the rats. Two different formulations of pectin hydrogel films, PH 2.5% and PH 5%, were prepared using a solvent evaporation method. MEBO® (moist exposed burn ointment), a commercial herbal formulation was used as a positive control. The progress of the wound healing was observed and compared between untreated normal rats, untreated diabetic rats, diabetic rats treated with MEBO®, diabetic rats treated with PH 2.5%, and diabetic rats treated with PH 5%. The results showed that diabetic rats treated with PH 5% healed faster than the untreated diabetic rats and diabetic rats treated with PH 2.5%. Interestingly, the diabetic rats treated with PH 5% healed as well as diabetic rats treated with MEBO®, where wounds were healed entirely on day 20. Nevertheless, both PH 2.5% and PH 5% showed a greater zone of inhibition than MEBO® when tested against Staphylococcus aureus.
The administration of drugs into the body is essential for the treatment of diseases. However, drugs need to reach the targeted site to be effective. Excipients such as polymers are used in drug formulations to ensure that drugs exert their therapeutic effects. Recently, plant-based polymers have been extensively explored in pharmaceutical research. These polymers, including gums and mucilages, are investigated for their roles in various pharmaceutical applications. The plant-based polymers have advantages compared to synthetic polymers due to their bioavailability, chemical inertness, non-toxicity and wide availability. When gums or mucilages are combined with other polymers, their final properties improve. In some instances, the characteristics of gums and mucilages such as swelling, flow and mucoadhesive properties are better than the abilities of synthetic materials. This article reviews the use of Hibiscus rosa-sinensis (HRS) mucilage as an excipient in several dosage forms to enhance drug delivery systems. Their physicochemical properties and mechanisms of action are also discussed. The review ends with a discussion of the limitations and future prospects of HRS mucilage in pharmaceutical applications.
26 June 2023 in Research Journal of Pharmacy and Technology
This article highlights recent progress in the development of polysaccharide-based formulations for the treatment of diabetic wounds. Wound healing is generally slower in diabetic patients than in non-diabetic individuals, which can be complicated into cellulitis, gangrene and foot abscess. Here, the influence of diabetes on the wound healing process and the potential effects of polysaccharide-based formulations on wounds associated with diabetes mellitus are described. Polysaccharides are excellent candidates for effective skin repair due to the characteristics of biodegradability, biocompatibility, and non-toxicity. Common polysaccharides employed in the development of diabetic wound care include cellulose, hyaluronic acid, and alginate. In addition, novel polysaccharides for diabetic wound care have been extracted from natural materials used for traditional medicine, such as Ganoderma lucidum, Periplaneta americana, and psyllium seed husk. Several strategies have been adopted, including crosslinking, grafting, quaternation, nanoformulation, and polymeric composites, to improve the physicochemical and mechanical attributes of polysaccharide-based formulations. These properties are crucial to the wound healing process by facilitating wound closure via accelerated re-epithelialization and collagen synthesis, as well as maintaining an optimal moist environment while minimizing the risk of infection and scar formation. The roles of stimuli-responsive polymers, controlled-release formulations, and bioactive polysaccharides in facilitating diabetic wound healing are also discussed.
22 July 2024 in Journal of Advanced Pharmaceutical Technology & Research
Candida species are the primary cause of candidiasis, a common yeast infection, with Candidaalbicans being the most prevalent pathogen. These infections often infiltrate the body through cutaneous and vaginal routes. Given the potential severity of some Candida infections, particularly invasive cases, there is a critical need for effective antifungal treatments. Controlled drug delivery strategies have been developed to achieve optimal release kinetics and precise targeting of active agents, especially in fungal infection therapeutics. Consequently, significant attention has been focused on exploring and utilizing bioadhesive polymers to enhance the performance of drug delivery systems for antifungal medications. Bioadhesive drug delivery systems aim to sustain the release of therapeutic agents, reducing the need for frequent dosing. This article provides a comprehensive review of scientific investigations into the use of antifungal drugs within bioadhesive drug delivery systems for treating candidiasis, locally and systemically. The evaluation covers the efficacy of these systems against candidiasis, factors affecting prolonged contact at the application site, and the underlying mechanisms of drug delivery.